$ACOR

Acorda Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$0.3 ▲8.421%

Extented Hours

VOLUME

190,329

DAY RANGE

0.2611 - 0.2974

52 WEEK

0.2611 - 4.9

Join Discuss about ACOR with like-minded investors

profile
@dros #droscrew
recently

Upgrades 6/17: $ABEV $ACOR $ATUS $BK $BOOT $CHTR $CPA $ENB $IR $MC $NOAH $PDCO $T $VEON . Downgrades 6/17: $BNL $CNST $CONE $CVAC $CWH $HNST $KIN $LPL $MSGE $NTRS $OHI $THO $VOYA $WGO $WRE

150 Replies 14 👍 13 🔥

profile
@TraderXx #StockTraders.NET
recently

$ACOR here come covers

139 Replies 12 👍 7 🔥

profile
@Neptune5045 #StockTraders.NET
recently

$ACOR was the easy no stress play

129 Replies 12 👍 11 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

nice $acor $wimi and $live this morning

69 Replies 10 👍 15 🔥

profile
@NFrenchTrader #StockTraders.NET
recently

nice > @Propner said: ACOR on the move

47 Replies 14 👍 6 🔥

PR
@Propner #StockTraders.NET
recently

ACOR on the move

123 Replies 10 👍 10 🔥

JC
@jcarlgohn #StockTraders.NET
recently

I totally just over-ruled my system because of an outside event...told myself never to do that...made $$$, but who knows, could be missing on outlier $ACOR or $DGLY

146 Replies 6 👍 6 🔥

JC
@jcarlgohn #StockTraders.NET
recently

Might regret not holding $ACOR

99 Replies 8 👍 11 🔥

JC
@jcarlgohn #StockTraders.NET
recently

In $ACOR too from .92833951

77 Replies 11 👍 12 🔥

JC
@jcarlgohn #StockTraders.NET
recently

anyone see the resume indication for $ACOR?

44 Replies 14 👍 11 🔥

ST
@StefanAman #StockTraders.NET
recently

$ACOR crazy move

86 Replies 11 👍 14 🔥

profile
@viking #StockTraders.NET
recently

$ACOR looking algoy

117 Replies 6 👍 10 🔥

profile
@viking #StockTraders.NET
recently

is $ACOR just up on air

82 Replies 10 👍 6 🔥

Key Metrics

Market Cap

6.73 M

Beta

0.62

Avg. Volume

209.89 K

Shares Outstanding

24.34 M

Yield

0%

Public Float

0

Next Earnings Date

2022-11-09

Next Dividend Date

Company Information

Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders. INBRIJA® (levodopa inhalation powder) is approved for intermittent treatment of OFF episodes in adults with Parkinson's disease treated with carbidopa/levodopa. INBRIJA is not to be used by patients who take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last two weeks. INBRIJA utilizes Acorda's innovative ARCUS® pulmonary delivery system, a technology platform designed to deliver medication through inhalation. Acorda also markets the branded AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.

CEO: Ron Cohen

Website:

HQ: 420 Saw Mill River Rd Ardsley, 10502-2605 New York

Related News